Purchase Order HHSN272201300935P
Award Date 8/27/13
Potential Completion Date 9/3/13
Potential Value $5.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. The contract is valued at $13,613.60 and was awarded on September 8, 2014, with a completion date of October 5, 2014. The contract does not have a set-aside designation. Illumina, a for-profit manufacturer of genetic sequencing and analysis equipment, has provided a range of sequencing systems, reagents, and...
- This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. The contract has a ceiling value of $3,161.60 and is for the provision of Illumina's sequencing systems, reagents, and related services to support genomic sequencing and analysis for research and diagnostic applications. The contract does not have a set-aside designation. Based on Illumina's history...
- This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the provision of sequencing kits, with a ceiling value of $7,012.50 and a period of performance from May 15, 2014 to May 23, 2014. The contract has no set-aside designation. Illumina has a history of providing...
- This is a firm fixed price purchase order issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Illumina, Inc. for sequencing kits. The contract has a ceiling value of $8,381.13 and a performance period ending on August 18, 2015. Illumina is a manufacturer of DNA sequencing and array-based solutions for genetic and genomic analysis. This award does not have a set-aside designation. Illumina has a history of providing sequencing instruments, reagents, and bioinformatics...
- This is a delivery order issued by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to Illumina, Inc. for the supply of biological materials. The firm-fixed-price contract has a ceiling value of $11,649.35 and a period of performance through August 31, 2015. Illumina is a for-profit manufacturer of genetic sequencing instruments and reagents, and has previously been awarded prime contracts and subcontracts by agencies including NIH,...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The contract, valued at $12,875.00, is for sequencing services to support NIAID's research and diagnostic efforts. Illumina has previously been awarded other prime federal contracts and subcontracts by...
- This is a firm fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. for $5,552.00. The award is not associated with a set-aside program. Illumina, a manufacturer of genetic sequencing systems and reagents, has provided similar products and services to support genomic sequencing and analysis for research and diagnostics across multiple federal agencies in the past. This...
- This is a firm fixed-price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. for the provision of Illumina biomedical sequencing instruments and related materials. The $7,998.65 contract is for the purchase of Illumina's sequencing systems, reagents, and consumables to support genomic research and diagnostics. Illumina is a leading manufacturer of genetic analysis...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Illumina, Inc. The $5,006.36 contract is for the provision of various Illumina sequencing systems, reagents, consumables, and related services and support to support genomic sequencing and analysis, with no set-aside designation. Illumina is a manufacturer of genetic and genomic analysis instruments and solutions, and...
- This is a firm fixed price Purchase Order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $11,937.60, is for the provision of unspecified "OTHER FUNCTIONS" and does not have a set-aside designation. Through past prime federal contract awards, Illumina has provided a range of goods and services, including sequencing...